Studies elucidated that the heterogeneity of the metastatic process in melanoma depends on the differences in the expression levels of MCT1, and revealed that the molecular mechanism involved lies in the fact that melanomas with high expression of MCT1 can utilize lactate to resist oxidative stress, and thus obtain a stronger metastatic capability.13,16. This evidence concerns the gene SLC16A1 and melanoma.